Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
RecruitingNot applicableNCT07102446
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this prospective, non-randomized clinical trial is to evaluate the effectiveness of a pharmacist-led Opioid Stewardship Program (OSP) in outpatient adults with chronic non-cancer pain. This study compared OSP implementation with a historical control to determine whether it reduces the incidence of high-risk opioid prescribing and improves patients' awareness, knowledge, and attitudes about opioid use.
Study details
- Official title
- Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
- Conditions
- Pain
- Chronic Pain
- Opioid Analgesia
- Opioid Use
- Interventions
- Other: Opioid Stewardship Program
- Sponsor
- Korea University Guro Hospital
- Collaborators
- Korea Hospital Pharmaceutical Education & Research Center; Korea University
- Start date
- 2025-06-27
- Primary completion
- 2025-12
- Sex
- All
- Age range
- from 19 Years to 79 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025) * Adults aged ≥19 years and \<80 years * Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose Exclusion Criteria: * Patients with active cancer * Patients diagnosed with sickle cell disease * Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE' * Pregnant patients * Patients who were prescribed opioid analgesics within the past month for postoperative pain management * Patients who were prescribed opioid analgesics within the past month for newly developed pain * Patients with communication difficulties * Patients who were prescribed buprenorphine for the treatment of opioid use disorder * Patients who are deemed inappropriate for study participation at the discretion of the investigator
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07102446